Design, synthesis, and antiviral evaluation of 2-chloro-5,6-dihalo-1- β-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections

Journal of Medicinal Chemistry

Volumn 40, Issue 5, 1997, Pages 811-818

  Zou, R ^a   Drach, J C ^a   Townsend, L B ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 BETA D RIBOFURANOSYLBENZIMIDAZOLE DERIVATIVE; ANTIVIRUS AGENT; BENZIMIDAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOMEGALOVIRUS INFECTION; DRUG DESIGN; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS;

ANTIVIRAL AGENTS; BENZIMIDAZOLES; CELL DIVISION; CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRUG DESIGN; HUMANS; KB CELLS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; RIBONUCLEOSIDES; SIMPLEXVIRUS;

EID: 0031058374     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960462g     Document Type: Article

References (32)